The pharmaceutical landscape for blood sugar is shifting, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this approach offers a less invasive way to provide GLP-1 drugs. https://arranepay863443.blogoscience.com/47684411/glp-1-patches-a-novel-approach-to-diabetes-treatment